Vendor, Frederick, MD, part of General Dynamics Corp.
Dynport Vaccine Company LLC
UEI LXNEGTYDR755, CAGE 1GFE1
17 awards and -$102,428,379 obligated between January 4, 2024 and September 28, 2026, 100% under full and open competition, against 6.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Department of the Army | $5,605,672 |
| National Institutes of Health | $1,720,556 |
| Defense Health Agency | $6,087 |
| Office of Assistant Secretary for Preparedness and Response | -$7,163,741 |
| Defense Contract Management Agency | -$102,596,953 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $7,044,147 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | $282,081 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | $6,087 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | -$7,163,741 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 17 |
| Delivery Order | 10 |
| Definitive Contract | 4 |
Hear when Dynport Vaccine Company LLC wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Dynport Vaccine Company LLC holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 2
- Obligated so far
- $5,605,672
- Soonest
- March 11, 2027
The 2 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to Department of the Army, by dollars.
| The Mitre CorporationMC Lean, VA | $3,923,058,766 |
| Caci Technologies, LLCChantilly, VA | $906,857,522 |
| Intuitive Research and Technology CorporationHuntsville, AL | $898,690,582 |
| Joint Technical Solutions, LLCHuntsville, AL | $253,024,519 |
| Janus Research Group, LLCEvans, GA | $243,122,420 |
| Fibertek, Inc.Herndon, VA | $194,261,185 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W911QY21C0093Definitive Contract, January 4, 2024, Full and Open Competition, 1 offers | W6QK ACC-APGDepartment of the Army | Administrative Modification to Revise Slin Description.NAICS 541715, PSC AC13 | $5,922,584 |
| 75N93022F00001Delivery Order, January 11, 2024, Full and Open Competition, 6 offers | National Institutes of Health NiaidNational Institutes of Health | Task Order 75N93022F00001 Base AwardNAICS 541715, PSC AN12 | $646,845 |
| 75N93023F00001Delivery Order, January 25, 2024, Full and Open Competition, 5 offers | National Institutes of Health NiaidNational Institutes of Health | EpctuNAICS 541715, PSC AN12 | $464,718 |
| 75N93022F00057Delivery Order, April 17, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | Phase I Task Area B -21-0013 - BaseNAICS 541711, PSC AN12 | $348,422 |
| 75N93021F00202Delivery Order, July 18, 2024, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | Phase 1NAICS 541711, PSC AN12 | $316,046 |
| 75N93025D00025September 30, 2025, Full and Open Competition, 37 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | "evaluation and Testing Services (Ets) for Vaccines and Other Biologics for Infectious Diseases.NAICS 541715, PSC AN11 | $10,000 |
| 0002Delivery Order, January 23, 2026, Full and Open Competition, 2 offers | Army Med Res Acq ActivityDefense Health Agency | Tafenoquine Clinical TrialsNAICS 541712, PSC AJ53 | $6,087 |
| 75N93022D00016August 15, 2024, Full and Open Competition, 6 offers | National Institutes of Health NiaidNational Institutes of Health | Early Phase Clinical Trial Units (Epctu)NAICS 541715, PSC AN12 | $0 |
| 75N93023D00016July 17, 2026, Full and Open Competition, 12 offers | National Institutes of Health NiaidNational Institutes of Health | EO14398, Rfo, Inv, Non-Commercial BotNAICS 541714, PSC AN11 | $0 |
| HHSN27200003Delivery Order, September 3, 2026, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541711, PSC AN12 | -$639 |
| HHSN27200006Delivery Order, August 8, 2024, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | Phase 1 Study Task Area BNAICS 541711, PSC AN12 | -$5,903 |
| 75N93020F00001Delivery Order, September 23, 2025, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | 1500005I Dynport Vaccine CompanyNAICS 541711, PSC AN12 | -$9,233 |
| 75N93019F00125Delivery Order, September 16, 2024, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | Task Area aNAICS 541711, PSC AN12 | -$17,304 |
| 75N93021F00001Delivery Order, September 28, 2026, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541711, PSC AN12 | -$32,396 |
| W911QY13C0056Definitive Contract, March 13, 2024, Full and Open Competition, 1 offers | W6QK ACC-APGDepartment of the Army | Extend Deadline for Termination Settlement Proposal Submission Date to 14 March 2024 Under Terminated Contract for FDA Licensure of a BioscaNAICS 541711, PSC 6505 | -$316,912 |
| HHSO100200600013CDefinitive Contract, December 31, 2024, Full and Open Competition, 8 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Close Contract and Deobligate Excess FundsNAICS 325414, PSC 6505 | -$7,163,741 |
| DAMD1798C8024Definitive Contract, February 5, 2024, Full and Open Competition, 4 offers | DCMA Mid-Atlantic (Baltimore)Defense Contract Management Agency | 199802!2100!1273!MD17 !us Army Medical Research Acq Act!damd1798c8024 !a!*!* !19971106!19971130!958462681!927921627!003242013!n!03543!dyntel | -$102,596,953 |
- Places of performance
- MarylandNorth Carolina
- Product and service codes
- AC13 National Defense R&D Services; Department Of Defense - Military; Experimental DevelopmentAN12 Health R&D Services; Health Care Services; Applied ResearchAN11 Health R&D Services; Health Care Services; Basic ResearchAJ53 General Science And Technology R&D Services6505 Drugs and BiologicalsAN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 51 across 17 awards